Biomet Microfixation and Oxford Performance Materials have developed an exclusive distribution agreement for OPM’s OsteoFab Patient Specific Cranial Device. The agreement gives Biomet exclusive global distribution rights to the cranial device, as well as OsteoFab craniomxillofacial implants. The OsteoFab technology uses a type of PEEK polymer that is biocompatible to bone and an additive manufacturing process to 3-D print.
More Articles on Devices:
13 Spine Devices Receive FDA 510(k) Clearance in March
5 Thoughts on Physician-Owned Distributorships
Orthofix Names Emily Buxton as CFO
More Articles on Devices:
13 Spine Devices Receive FDA 510(k) Clearance in March
5 Thoughts on Physician-Owned Distributorships
Orthofix Names Emily Buxton as CFO